FDA Inspection 1084042 — Prestige Ameritech

Prestige Ameritech — FEI 3005022483

The FDA completed an inspection of Prestige Ameritech on March 27, 2019 in North Richland Hills, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 27, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
North Richland Hills, TX (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
63321 CFR 803.17(a)(3)Lack of System for Timely Submission of Reports